Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 RAs in Obese Patients
NCT03671733Phase 3Unknown
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Sep 2018
- Primary completion
- Sep 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide, exenatide in obesity, sponsored by Xiangya Hospital, Central South University. Status: unknown.
02
Drugs
liraglutideexenatide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03671733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671733.